MiR-494 is an independent prognostic factor and promotes cell migration and invasion in colorectal cancer by directly targeting PTEN

International Journal of Oncology

Volumn 45, Issue 6, 2014, Pages 2486-2494

  Sun, Hai Bing ^a   Chen, Xi ^a   Ji, Hong ^a   Wu, Tao ^a   Lu, Hong Wei ^a   Zhang, Yan ^a   Li, Hua ^a   Li, Yi Ming ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Colorectal cancer; Metastasis; MiR 494; Prognosis; PTEN

Indexed keywords

3' UNTRANSLATED REGION; MICRORNA; MIRN494 MICRORNA, HUMAN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PTEN PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ADULT; AGED; BIOSYNTHESIS; CELL MOTION; CELL PROLIFERATION; COLORECTAL TUMOR; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; RNA INTERFERENCE; TUMOR INVASION;

3' UNTRANSLATED REGIONS; ADULT; AGED; CELL MOVEMENT; CELL PROLIFERATION; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; PTEN PHOSPHOHYDROLASE; RNA INTERFERENCE;

EID: 84907693981     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2665     Document Type: Article

References (39)

1. Siegel R, Ma J, Zou Z and Jemal A: Cancer statistics, 2014. CA Cancer J Clin 64:9-29, 2014.
2. van den Berg A, Mols J and Han J: RISC-target interaction: cleavage and translational suppression. Biochim Biophys Acta 1779:668-677, 2008.
3. Calin GA and Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer 6:857-866, 2006.
4. Kumar MS, Lu J, Mercer KL, Golub TR and Jacks T: Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet 39:673-677, 2007.
5. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297, 2004.
6. Croce CM and Calin GA: miRNAs, cancer, and stem cell division. Cell 122:6-7, 2005.
7. Gregory RI and Shiekhattar R: MicroRNA biogenesis and cancer. Cancer Res 65:3509-3512, 2005.
8. Lu J, Getz G, Miska EA, et al: MicroRNA expression profiles classify human cancers. Nature 435:834-838, 2005.
9. Volinia S, Calin GA, Liu CG, et al: A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103:2257-2261, 2006.
10. Lujambio A, Calin GA, Villanueva A, et al: A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci USA 105:13556-13561, 2008.
11. Ma Y, Zhang P, Wang F, et al: miR-150 as a potential biomarker associated with prognosis and therapeutic outcome in colorectal cancer. Gut 61:1447-1453, 2012.
12. Almeida MI, Nicoloso MS, Zeng L, et al: Strand-specific miR-28-5p and miR-28-3p have distinct effects in colorectal cancer cells. Gastroenterology 142:886-896, e9, 2012.
13. Pichler M, Ress AL, Winter E, et al: MiR-200a regulates epithelial to mesenchymal transition-related gene expression and determines prognosis in colorectal cancer patients. Br J Cancer 110:1614-1621, 2014.
14. Hwang WL, Jiang JK, Yang SH, et al: MicroRNA-146a directs the symmetric division of Snail-dominant colorectal cancer stem cells. Nat Cell Biol 16:268-280, 2014.
15. Yang X, Zeng Z, Hou Y, et al: MicroRNA-92a as a potential biomarker in diagnosis of colorectal cancer: a systematic review and meta-analysis. PLoS One 9: e88745, 2014.
16. Liu Y, Zhou Y, Feng X, et al: Low expression of microRNA-126 is associated with poor prognosis in colorectal cancer. Genes Chromosomes Cancer 53:358-365, 2014.
17. Zhao JJ, Yang J, Lin J, et al: Identification of miRNAs associated with tumorigenesis of retinoblastoma by miRNA microarray analysis. Childs Nerv Syst 25:13-20, 2009.
18. Shen YL, Jiang YG, Greenlee AR, Zhou LL and Liu LH: MicroRNA expression profiles and miR-lOa target in anti-benzo[a] pyrene-7, 8-diol-9, 10-epoxide-transformed human 16HBE cells. Biomed Environ Sci 22:14-21, 2009.
19. Liu Y, Lai L, Chen Q, et al: MicroRNA-494 is required for the accumulation and functions of tumor-expanded myeloid-derived suppressor cells via targeting of PTEN. J Immunol 188:5500-5510, 2012.
20. Kwak SY, Yang JS, Kim BY, Bae IH and Han YH: Ionizing radiation-inducible miR-494 promotes glioma cell invasion through EGFR stabilization by targeting pl90B rhoGAP. Biochim Biophys Acta 1843:508-516, 2014.
21. Yamanaka S, Campbell NR, An F, et al: Coordinated effects of microRNA-494 induce G2/M arrest in human cholangiocarcinoma. Cell Cycle 11:2729-2738, 2012.
22. Olaru AV, Ghiaur G, Yamanaka S, et al: MicroRNA downregulated in human cholangiocarcinoma control cell cycle through multiple targets involved in the Gl/S checkpoint. Hepatology 54:2089-2098, 2011.
23. Li X, Luo F, Li Q, et al: Identification of new aberrantly expressed miRNAs in intestinal-type gastric cancer and its clinical significance. Oncol Rep 26:1431-1439, 2011.
24. Leibovitz A, Stinson JC, McCombs WB 3rd, McCoy CE, Mazur KC and Mabry ND: Classification of human colorectal adenocarcinoma cell lines. Cancer Res 36:4562-4569, 1976.
25. Sawai H, Yasuda A, Ochi N, et al: Loss of PTEN expression is associated with colorectal cancer liver metastasis and poor patient survival. BMC Gastroenterol 8:56, 2008.
26. Bowen KA, Doan HQ, Zhou BP, et al: PTEN loss induces epithelial-mesenchymal transition in human colon cancer cells. Anticancer Res 29:4439-4449, 2009.
27. Liu L, Jiang Y, Zhang H, Greenlee AR and Han Z: Overexpressed miR-494 down-regulates PTEN gene expression in cells transformed by anti-benzo (a) pyrene-trans-7, 8-dihydrodiol-9, 10-epoxide. Life Sci 86:192-198, 2010.
28. Ohdaira H, Sekiguchi M, Miyata K and Yoshida K: Micro-RNA-494 suppresses cell proliferation and induces senescence in A549 lung cancer cells. Cell Prolif 45:32-38, 2012.
29. Lim L, Balakrishnan A, Huskey N, et al: MicroRNA-494 within an oncogenic microRNA megacluster regulates Gl/S transition in liver tumorigenesis through suppression of mutated in colorectal cancer. Hepatology 59:202-215, 2014.
30. Romano G, Acunzo M, Garofalo M, et al: MiR-494 is regulated by ERK1/2 and modulates TRAIL-induced apoptosis in non-small-cell lung cancer through BIM down-regulation. Proc Natl Acad Sci USA 109:16570-16575, 2012.
31. Molinari F and Frattini M: Functions and regulation of the PTEN gene in colorectal cancer. Front Oncol 3:326, 2014.
32. Sansal I and Sellers WR: The biology and clinical relevance of the PTEN tumor suppressor pathway. J Clin Oncol 22:2954-2963, 2004.
33. Castellino RC and Durden DL: Mechanisms of disease: the PI3K-Akt-PTEN signaling node - an intercept point for the control of angiogenesis in brain tumors. Nat Clin Pract Neurol 3:682-693, 2007.
34. Grille SJ, Bellacosa A, Upson J, et al: The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Res 63:2172-2178, 2003.
35. Vogt PK, Gymnopoulos M and Hart JR: PI 3-kinase and cancer: changing accents. Curr Opin Genet Dev 19:12-17, 2009.
36. Zhang S and Yu D: PI (3) king apart PTEN's role in cancer. Clin Cancer Res 16:4325-4330, 2010.
37. Song MS, Salmena L and Pandolfi PP: The functions and regulation of the PTEN tumour suppressor. Nat Rev Mol Cell Biol 13:283-296, 2012.
38. Stewart AL, Mhashilkar AM, YangXH, et al: PI3 kinase blockade by Ad-PTEN inhibits invasion and induces apoptosis in RGP and metastatic melanoma cells. Mol Med 8:451-461, 2002.
39. Tamura M, Gu J, Matsumoto K, Aota S, Parsons R and Yamada KM: Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 280:1614-1617, 1998.